Updated Sep. 6, 2013 at 7:03 a.m.

Premium Lock Pozen's 'safer aspirin' expected to ride on Sanofi's Plavix success

Published: 2013-09-06 07:03:00
Updated: 2013-09-06 07:03:32

Chairman, CEO John Plachetka Chairman, CEO John Plachetka Image 1 of 2 · Next Image…

Pozen believes that Sanofi is the best possible big pharma partner to sell its 'safer on the stomach' aspirin. Read how this drug will fits in Sanofi's drug portfolio....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll